Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
60.50
+2.30 (3.95%)
At close: Feb 10, 2026
Market Cap6.50B +30.1%
Revenue (ttm)9.52B +28.6%
Net Income537.75M +28.4%
EPS4.99 +27.6%
Shares Out107.42M
PE Ratio12.13
Forward PEn/a
Dividend1.40 (2.31%)
Ex-Dividend DateNov 20, 2025
Volume1,250,965
Average Volume696,496
Open58.60
Previous Close58.20
Day's Range58.60 - 61.80
52-Week Range45.50 - 65.80
Beta-0.08
RSI70.81
Earnings DateJan 28, 2026

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. Navana Pharmaceuticals PLC was incorporated in 1986 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 4,798
Stock Exchange Dhaka Stock Exchange
Ticker Symbol NAVANAPHAR
Full Company Profile

Financial Performance

In fiscal year 2025, Navana Pharmaceuticals's revenue was 8.84 billion, an increase of 28.19% compared to the previous year's 6.90 billion. Earnings were 487.81 million, an increase of 20.56%.

Financial Statements